Artificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy public health measures.
AAC recently published a commentary on the impact of AI in infectious diseases and we have a conversation with the lead author of the manuscript and a expert guest who is applying these concepts in real time.
- Basic concepts of AI and different applications.
- How AI can affect the practice of infectious diseases and antimicrobial research.
- Specific examples in which AI may have a transformative effect in the future.
- Lilian Abbo, MD MBA. Associate CMO Infectious Diseases, Professor of Clinical Infectious Diseases, Jackson Health System, University of Miami Miller School of Medicine, Miami Transplant Institute
- Masayuki Nigo, MD, MSc. Associate Professor of Clinical Medicine, Houston Methodist Hospital, Section of Transplant Infectious Diseases.
- Disrupting the infectious disease ecosystem in the digital precision health era innovations and converging emerging technologies
This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up.
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.